Repository logo
 

Genetic determinants of micronucleus formation in vivo.

Published version
Peer-reviewed

Repository DOI


Change log

Authors

Barlas, B 
McIntyre, RE 
Salguero, I 

Abstract

Genomic instability arising from defective responses to DNA damage1 or mitotic chromosomal imbalances2 can lead to the sequestration of DNA in aberrant extranuclear structures called micronuclei (MN). Although MN are a hallmark of ageing and diseases associated with genomic instability, the catalogue of genetic players that regulate the generation of MN remains to be determined. Here we analyse 997 mouse mutant lines, revealing 145 genes whose loss significantly increases (n = 71) or decreases (n = 74) MN formation, including many genes whose orthologues are linked to human disease. We found that mice null for Dscc1, which showed the most significant increase in MN, also displayed a range of phenotypes characteristic of patients with cohesinopathy disorders. After validating the DSCC1-associated MN instability phenotype in human cells, we used genome-wide CRISPR-Cas9 screening to define synthetic lethal and synthetic rescue interactors. We found that the loss of SIRT1 can rescue phenotypes associated with DSCC1 loss in a manner paralleling restoration of protein acetylation of SMC3. Our study reveals factors involved in maintaining genomic stability and shows how this information can be used to identify mechanisms that are relevant to human disease biology1.

Description

Keywords

Animals, Humans, Mice, Chromosomes, DNA Damage, Genomic Instability, Micronuclei, Chromosome-Defective, Phenotype, Sirtuin 1, Synthetic Lethal Mutations

Journal Title

Nature

Conference Name

Journal ISSN

0028-0836
1476-4687

Volume Title

627

Publisher

Springer Science and Business Media LLC
Sponsorship
MRC (MC_UU_00006/2)
Medical Research Council (MC_UU_12015/2)
Cancer Research UK (C6946/A24843)
European Commission Horizon 2020 (H2020) ERC (855741)
Wellcome Trust (203144/A/16/Z)
Wellcome Trust (206388/Z/17/Z)
Cancer Research UK (18796)
Cancer Research UK (18795)
Cancer Research UK (DRCPGM\100005)